NCT07422298 A Study to Evaluate the Effect of BMS-986278 on Cardiac Repolarization in Healthy Participants Status RECRUITING Phase PHASE1
NCT07412704 A Study of BMS-986528 in Participants With Refractory Rheumatoid Arthritis Status NOT_YET_RECRUITING Phase PHASE1/PHASE2
NCT07388277 CC-97540 in Patients With Antineutrophil Cytoplasmic Antibody-associated Vasculitis Status RECRUITING Phase PHASE1/PHASE2
NCT07383025 Mavacamten Post-marketing Surveillance in Patients With Obstructive Hypertrophic Cardiomyopathy in Japan Status RECRUITING Phase N/A
NCT07379827 Effectiveness and Adverse-effect Switch Evaluation of Xanomeline and Trospium Chloride (KarXT) Status RECRUITING Phase N/A
NCT07361510 A Study to Evaluate the Efficacy of Pumitamig Versus Pembrolizumab in Participants With Previously Untreated Advanced Non-Small Cell Lung Cancer and PD-L1 ≥ 50%. (ROSETTA Lung-202) Status RECRUITING Phase PHASE3
NCT07361497 A Study to Evaluate Pumitamig Versus Durvalumab Following Concurrent Chemoradiation Therapy in Participants With Unresectable Stage III Non-small Cell Lung Cancer (NSCLC) (ROSETTA Lung-201) Status RECRUITING Phase PHASE3
NCT07361289 A Study to Assess the Real-World Effectiveness of Mavacamten in Adult Patients With Obstructive Hypertrophic Cardiomyopathy in China Status RECRUITING Phase N/A
NCT07355335 Ziftomenib + Mezigdomide in Adolesc. and Adults w/ R/R AML Status NOT_YET_RECRUITING Phase PHASE1
NCT07348393 A Phase 2, Single Arm Multicenter, Study Testing Mezigdomide, Carfilzomib, and Dexamethasone (480Kd) in Participants With Relapsed or Refractory Multiple Myeloma (RRMM) Status NOT_YET_RECRUITING Phase PHASE2
NCT07339254 Experiences w/ & Attitudes Towards Immune Chckpt Inhibitors in NSCLC Patients Single Center Survey Based Study Status RECRUITING Phase N/A
NCT07325136 A Study to Assess the Safety and Tolerability of BMS-986525 Alone and in Combination With Nivolumab in Participants With Relapsed/Refractory Small Cell Lung Cancer Status RECRUITING Phase PHASE1/PHASE2
NCT07297212 A Clinical Trial Testing the Safety of the Investigational Drug Pumitamig (BNT327) and How Well it Works in Patients With Recurrent Glioblastoma Status RECRUITING Phase PHASE2
NCT07293351 A Study to Evaluate the Safety, Tolerability, and Efficacy of Pumitamig Alone or in Combination With Ipilimumab or Cabozantinib in Participants With Advanced Renal Cell Carcinoma (RCC) (ROSETTA RCC-208) Status RECRUITING Phase PHASE1/PHASE2
NCT07291076 A Study to Evaluate the Safety and Tolerability of Pumitamig Alone or In Combination With Ipilimumab in Participants With First-Line Advanced or Unresectable Hepatocellular Carcinoma (HCC) (ROSETTA HCC-206) Status RECRUITING Phase PHASE1/PHASE2
NCT07288567 A Study to Evaluate the Efficacy and Safety of KarXT for the Treatment of Schizophrenia in Adolescents (EMERGENT TEEN) Status RECRUITING Phase PHASE3
NCT07285798 A Study of KarXT + KarX-EC for Treatment of Irritability in Children and Adolescents With Autism Spectrum Disorder Status NOT_YET_RECRUITING Phase PHASE3
NCT07284745 A Study of KarXT + KarX-EC for Treatment of Irritability in Children and Adolescents With Autism Status NOT_YET_RECRUITING Phase PHASE3